Work

Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.2030

Authors: Ina Ly, Leland Richardson, Mofei Liu, Alona Muzikansky, Kevin Lou, David A. Reardon, Isabel Arrillaga-Romany, Deborah Anne Forst, Justin T. Jordan, Eudocia Quant Lee, Jorg Dietrich, Lakshmi Nayak, Patrick Y. Wen, Ugonma Nnenna Chukwueke, Anita Giobbie-Hurder, Bryan D. Choi, Tracy Batchelor, Jayashree Kalpathy-Cramer, William T. Curry, Elizabeth R. Gerstner

Institutions: Massachusetts General Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Athinoula A. Martinos Center for Biomedical Imaging, Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Comprehensive Cancer Network

OpenAlex ID: W4286298849

Cites:

Cited by: 3

Related to: 10